Ensuring Healthcare Resilience in Uncertain Times

In an era of geopolitical instability, economic shifts, and increasing healthcare demands, how can Norway ensure a resilient and sustainable healthcare system? This meeting will explore the role of international collaboration, public-private partnerships, and strategic investments in securing patients’ access to life-saving medicines, medical technologies, and healthcare services in uncertain times.

The program begins with a panel discussion on "Building Resilience Through Collaboration", featuring leaders from the public and private sectors as well as patient organizations. After a short mingling break, the spotlight turns to a Political Hot Seat on Accountability and Action, where cross-party politicians will face direct questions from panelists and key healthcare stakeholders on how they plan to deliver concrete solutions.

Panel 1:
Dr. Trygve Ottersen - NOMA (DMP)
Dr. Cathrine Lofthus - Norwegian Directorate of Health
Magne Wang Fredriksen - LHL
Kirsti Nyhus - Abbvie
Anne-Lie Öberg - Medtronic

Panel 2:
Truls Vasvik - Arbeiderpartiet
Lars Løvold - Fremskrittspartiets Ungdom
Mahmoud Farahmand - Høyre

Thank you to our partners Abbvie, Amgen, AstraZeneca, Bayer, Bristol Myers Squibb, Boehringer Ingelheim, Boston Scientific, GSK, Johnson & Johnson, Merck, MSD, Medtronic, Novartis, Pfizer, Roche, Sanofi, and Takeda.